Columns
    The Atlantic
    Fortune
    Tech Review
    The Fiscal Times
Blog: Experimental Man
Appearances
Biotech Nation
    Podcasts
The Grotto
BioAgenda Institute
Personalized Health Project


Videos of Speeches
When I'm 164
   TEDx Brussels
BioBabel: Making Sense Of Big Data
   TEDx Berkeley
Experimental Man
    NY Academy of Sciences
Creative Disruptions
    Chautauqua




RECENT ARTICLES AND SUCH

Should Science Build a Better You?
THE NEW YORK TIMES
SUNDAY REVIEW

Your Cancer, Your Cure: How Genetic Tests Are Saving Lives
DISCOVER

How long do you want to live?
THE NEW YORK TIMES

A Little Device That's Trying to Read Your Thoughts
THE NEW YORK TIMES

Should We Patent Our DNA? A Lesson from the History of Radio
THE ATLANTIC

The Brain-Computer Interface That Let a Quadriplegic Woman Move a Cup
THE ATLANTIC

Why do the Best and Brightest End Up in Silicon Valley, and Not DC?
THE ATLANTIC

Destroying Medicine to Rebuild It: Eric Topol on Patients Using Data
THE ATLANTIC

Redesigning People: How Medtech Could Expand Beyond the Injured
THE ATLANTIC

Growing Heart Cells Just for You
TECHNOLOGY REVIEW

China: the Next Biotech Superpower?
FORTUNE

100,000 Genomes: profile of George Church
NEW YORK TIMES

Do You Have a Secret? Wikileaks, Pharma, and DNA
SFGATE.COM

Oxytocin, the Tucson Shooter, and "us versus them"
SFGATE.COM

How to Reboot the BioScience Revolution
FORTUNE

Venter and artificial life
FORTUNE

Oil: Time to reboot
THE FISCAL TIMES

Pharma and biotech: Is there love?
FORTUNE

The great DNA letdown
FORTUNE

What DNA, patents and Lady Gaga have in common
FORTUNE

Life at All Costs
5-Part Series
THE FISCAL TIMES


 

SHORT BIO

David Ewing Duncan is an award-winning, best-selling author of eight books published in 19 languages; he is a journalist and a television, radio and film producer and correspondent. His most recent book is When I'm 164: The new science of radical life extension, and what happens if it succeeds (TED Books). He is a Correspondent for The Atlantic, and the Chief Correspondent of public radio's Biotech Nation, heard on NPR Talk. David writes for The New York Times, Fortune , Wired, National Geographic, Discover, Atlantic Monthly, and many other publications. He is the Founding Director of the Center of Life Science Policy at UC Berkeley. He has been a commentator on NPR's Morning Edition, and a contributing editor for Wired, Discover and Conde Nast Portfolio. He is a former special correspondent and producer for ABC Nightline and a correspondent for NOVA's ScienceNOW! David has won numerous awards including the Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. He is at work on a TED book on extreme aging. David lives in San Francisco.

David on Facebook: David Ewing Duncan
David on Twitter: Duncande

LONG BIO

David Ewing Duncan is an award-winning, best-selling author of eight books and numerous essays, articles and short stories; and a television, radio and film producer and correspondent. He is a Correspondent for Atlantic.com; he is also the Chief Correspondent for public radio's "Biotech Nation", heard on NPR Talk. He writes for the New York Times, Fortune, Wired, Discover, Atlantic, National Geographic, and many other publications. At UC Berkeley he is the Founding Director of the Center for Life Science Policy. David's most recent book is When I'm 164: The new science of radical life extension, and what happens if it succeeds (TED Books). He also wrote the bestselling Experimental Man: What one man's body reveals about his future, your health, and our toxic world (Wiley). His previous book was Masterminds: Genius, DNA and the Quest to Rewrite Life (Harper Perennial). He wrote the international bestseller Calendar: Humanity's Epic Struggle to Determine a True and Accurate Year (Harper-Collins/Avon), published in 19 languages, and a bestseller in 14 countries.

David has been a Contributing Editor and columnist for Conde Nast Portfolio, and a Contributing Editor for Wired, Discover and MIT Technology Review; he has been a longtime commentator for NPR's "Morning Edition", and a special correspondent and producer for ABC's Nightline and 20/20. He has been a correspondent for NOVA's ScienceNow!, and a producer for Discovery Television. He has written for Harper' s, Atlantic Monthly, Smithsonian, Outside, The Telegraph, The Guardian, The Washington Post Book World, The San Francisco Chronicle, and The New York Times, among others

In 2003, David won the prestigious Magazine Story of the Year Award from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing.

David is the Founder and Editorial Director of the BioAgenda Institute, an independent, non-profit program of events and educational initiatives that discusses and analyzes crucial issues in life sciences -- which is being folded into the new Center for Life Science Policy at UC Berkeley. He has been the host of the annual BioAgenda Summit.

David's other books include the bestselling Pedaling the Ends of the Earth (Simon & Schuster), about his bicycle expedition around the world, and Hernando Soto: A Savage Quest in the Americas, called "an astonishing tour de force" by the New York Times Book Review. He wrote Residents: The Perils and Promise of Educating Young Doctors (Scribner) and Cape to Cairo: An African Odyssey (Grove Atlantic). His fiction has appeared in two anthologies. He has taught creative writing at Stanford University. He works at the San Francisco Writer's Grotto, and lives in San Francisco.



HAVE DAVID SPEAK TO YOUR GROUP!
Inquiries click here -- watch a video.

RECENT NEWS

David Giving Talks Hither and Yon
StrataRx, Health 2.0, Rock Health, TEDxSF, Cleveland Clinic, Litquake and more.

Third Annual Henrietta Lacks Memorial Lecture
David gives talk at Johns Hopkins on October 6. Info here.

31,321 people have voted in survey
How long do you want to live? Vote here.

New Website: www.whenim164.com
Take the survey: how long do you want to live? Find out more about the book. More

David a Correspondent for The Atlantic
Check out his column! More

David to Write TED Book
On his TEDx talk: "Will you still need me, will you still feed me, when I'm 164" More

New Experimental Man Site
Technology Review debuts EM site with articles, videos, blogs... More

David's Full Genome Sequenced
All of his DNA, thanks to Complete Genomics and the Personal Genome Project. More.

PHP Summit in SF
On April 29, David hosted 50 life science leaders in SF about how to hasten the pace of personalized health. More.

New PHP Website Launched
The Personalized Health Project has a new website with videos, study, projects, and more.

David Authors New Study
Kauffman Foundation publishes "The Personalized Health Project", an 82-page study. More.

New Column
Innovation Nation: 100 Best (and Worst) Ideas, coming soon in The Fiscal Times. More.

The Making Of The Manifesto
Kauffman Foundation's 2011 "Thoughtbook" Publishes "The Making of the Personalized Health Manifesto"

David launches a Manifesto
On October 13 the Personalized Health Manifesto is launched, sponsored by the Kauffman Foundation
Press Release
Manifesto

Endorse the Manifesto!
Join us in calling for a new age of healthcare - 500 names by December 31! More..

Experimental Man Best of 2009
Library Journal names book a Best Sci-Tech Book

5-Part Series in The Fiscal Times
New website runs a series on end-of-life issues.

>> News Archive Page